Capital Asset Advisory Services’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.75M | Sell |
6,514
-98
| -1% | -$41.3K | 0.13% | 97 |
|
|
2025
Q1 | $3.23M | Buy |
6,612
+537
| +9% | +$263K | 0.16% | 85 |
|
|
2024
Q4 | $3.23M | Buy |
6,075
+127
| +2% | +$67.6K | 0.16% | 87 |
|
|
2024
Q3 | $3.54M | Buy |
5,948
+308
| +5% | +$183K | 0.18% | 74 |
|
|
2024
Q2 | $3M | Buy |
5,640
+1,362
| +32% | +$724K | 0.16% | 77 |
|
|
2024
Q1 | $2.48M | Sell |
4,278
-318
| -7% | -$184K | 0.14% | 90 |
|
|
2023
Q4 | $2.44M | Buy |
4,596
+173
| +4% | +$91.8K | 0.15% | 86 |
|
|
2023
Q3 | $2.18M | Buy |
4,423
+385
| +10% | +$190K | 0.15% | 82 |
|
|
2023
Q2 | $2.14M | Buy |
4,038
+191
| +5% | +$101K | 0.15% | 78 |
|
|
2023
Q1 | $2.22M | Buy |
3,847
+93
| +2% | +$53.6K | 0.16% | 73 |
|
|
2022
Q4 | $2.11M | Sell |
3,754
-194
| -5% | -$109K | 0.17% | 72 |
|
|
2022
Q3 | $2M | Sell |
3,948
-225
| -5% | -$114K | 0.26% | 51 |
|
|
2022
Q2 | $2.27M | Sell |
4,173
-123
| -3% | -$66.9K | 0.25% | 60 |
|
|
2022
Q1 | $2.54M | Buy |
4,296
+1,181
| +38% | +$698K | 0.27% | 54 |
|
|
2021
Q4 | $2.08M | Buy |
3,115
+522
| +20% | +$348K | 0.22% | 62 |
|
|
2021
Q3 | $1.48M | Buy |
2,593
+773
| +42% | +$442K | 0.17% | 85 |
|
|
2021
Q2 | $919K | Buy |
1,820
+157
| +9% | +$79.3K | 0.1% | 144 |
|
|
2021
Q1 | $759K | Buy |
1,663
+258
| +18% | +$118K | 0.11% | 168 |
|
|
2020
Q4 | $655K | Buy |
1,405
+380
| +37% | +$177K | 0.12% | 153 |
|
|
2020
Q3 | $453K | Buy |
1,025
+10
| +1% | +$4.42K | 0.09% | 176 |
|
|
2020
Q2 | $413K | Buy |
1,015
+95
| +10% | +$38.7K | 0.09% | 204 |
|
|
2020
Q1 | $307K | Buy |
920
+45
| +5% | +$15K | 0.08% | 215 |
|
|
2019
Q4 | $296K | Buy |
+875
| New | +$296K | 0.07% | 272 |
|